Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04269044 Not yet recruiting - Clinical trials for Electrocardiogram Electrode Site Reaction

The Efficacy of a Novel, Non-contact EKG in the NICU

Start date: March 15, 2020
Phase:
Study type: Observational

We will be comparing a novel, non-contact EKG waveform and heart rate to the standard of care, contact-based EKG waveform and heart rate in neonates, who have sensitive skin.

NCT ID: NCT04268524 Not yet recruiting - Clinical trials for Old World Cutaneous Leishmaniasis

Randomised Clinical Trial for New Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan

Start date: February 1, 2021
Phase: Phase 3
Study type: Interventional

randomised control clinical trial to evaluate miltefosine, thermotherapy and the combination miltefosine-thermotherapy are effective, safe and tolerable alternative treatment options to treat cutaneous leishmaniasis caused by L. tropica, in Pakistan compared to the standard of care.

NCT ID: NCT04268043 Not yet recruiting - Clinical trials for Anesthesia Intubation Complication

Comparation of Proseal Laryngeal Mask Airway With Flexible Laryngeal Airway Mask

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

Objective To investigate the comparative effect of proseal laryngeal mask airway and flexible laryngeal airway mask during otitis media surgery. Methods 200 patients of ASA I or II classification, 18-65 years old, BMI<30 kg/m2 undergoing otitis media surgery are randomly divided into two groups (Group P with proseal laryngeal mask airway and Group F with flexible laryngeal airway mask, respectively). After induction, selecting a appropriate size of LMA to patient,s weight, using the standard index finger-guided technique inserting the LMA, and then the patients were ventilated mechanically. The success rate of inserting laryngeal mask, the intubation time, surgery time and wake time were also recorded. Tidal volume and leakage pressure in patients with supine and lateral positioning were assessed respectively. The scale of fiberoptic bronchoscopy was also recorded to show airway exposure. Related complications such as sore throat, hoarseness, cough, laryngospasm, bloating, nausea and vomiting, soft tissue injury, blood residue after pulling out the LMA were analyzed.Postoperative voice and laryngopharyngeal symptom are also recorded.

NCT ID: NCT04267042 Not yet recruiting - Clinical trials for Chronic Rhinosinusitis With Nasal Polyps

Comparing Budesonide Via MAD or INSI Prospective Cohort Study

Start date: February 3, 2020
Phase: Early Phase 1
Study type: Interventional

Chronic Rhinosinusitis (CRS) is a common disorder in North America, affecting more than 31 million people annually. Common therapy for CRS includes intranasal corticosteroids (INCS) such as budesonide. At our centre , the current practice is to administer budesonide two ways: the mucosal atomization device (MAD), which is a nasal spray or impregnated budesonide in nasal saline irrigation (INSI), which is a nasal rinse. Our study aims to see which method of administering budesonide has the best treatment outcomes after sinus surgery. This study will follow patients over a six-month period of time.

NCT ID: NCT04266730 Not yet recruiting - Clinical trials for Squamous Cell Carcinoma of Head and Neck

Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab

PANDA-VAC
Start date: August 22, 2024
Phase: Phase 1
Study type: Interventional

This is a single center, open-label phase I clinical trial designed to determine the safety of personalized and adjusted neoantigen peptide vaccine (PANDA-VAC) administered concurrently with pembrolizumab in subjects with advanced squamous non-small cell lung cancer (NSCLC) or squamous cell carcinoma of head and neck (SCCHN).

NCT ID: NCT04265729 Not yet recruiting - Clinical trials for Complex Conditions, Including Impairment of the GI Tract

Neocate In Infants and Children With Complex Conditions

NICC
Start date: March 2020
Phase: N/A
Study type: Interventional

Infants and young children up to 10 years of age with a complex condition involving the gastrointestinal tract are at risk of poor nutritional status, including faltering growth. Due to the complex condition, standard nutrition is often not tolerated and causes gastrointestinal symptoms. Formulas in which protein is replaced by its smallest elements, amino acids are easier for the body to digest and absorb. These formulas might be tolerated better and reduce gastrointestinal symptoms in infants and young children with complex conditions. The objectives of the present, exploratory study are to gain clinical evidence related to the nutritional status and gastrointestinal tolerance in infants and young children with complex conditions receiving Neocate as their primary source of nutrition. Additional objectives are to describe the nutritional and pharmacological management of these infants and young children. Study duration for each participant will be 52 weeks at maximum.

NCT ID: NCT04264039 Not yet recruiting - B-cell Lymphoma Clinical Trials

Anti-CD19 U-CAR-T Cell Therapy for B Cell Hematologic Malignancies

Start date: April 1, 2020
Phase: Early Phase 1
Study type: Interventional

The stunning response rate of anti-CD19(cluster of differentiation antigen 19) auto-CAR(chimeric antigen receptor)-T cell therapy brings hope to patients with relapsed or refractory B-cell hematologic malignancies. However, based on open clinical trials, using patients' T cells might encounter the failure of apheresis available T cells, even if successful, the time needed for the manufacture could also cause the irreversible disease progress. Furthermore, the cost of auto-CAR-T cells is not affordable for most patients. So to provide an accessible and affordable anti-CD19 CAR-T cell therapy for patients with B-cell hematologic malignancies, we launch such a trial that using the edited T cells from healthy donors to manufacture universal CAR-T cells and adapt it in patients with CD19+ B-cell leukemia or lymphoma.

NCT ID: NCT04263870 Not yet recruiting - Clinical trials for Gastroesophageal Junction Adenocarcinoma

Conversion Therapy With Sintilimab Plus CAPOX in Patients With Unresectable Locally Advanced or Limited Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

CTSCAPOXSEA
Start date: March 2020
Phase: Phase 2
Study type: Interventional

This study aims to evaluate the efficacy and safety of Sintilimab plus CAPOX in the conversion therapy for patients with unresectable locally advanced or limited metastatic adenocarcinoma of the stomach or esophagogastric junction

NCT ID: NCT04263805 Not yet recruiting - Clinical trials for The Study Focus on no Specific Condition

A Vignette-based Randomized Controlled Trial to Evaluate the Impact of Research Climate on Research Practices of Doctoral Students

Start date: February 1, 2020
Phase: N/A
Study type: Interventional

This study aims to evaluate the impact of research climate on PhD students' research practice (i.e., an environment where their peer (i.e., a post-doc researcher) had detrimental practice in a similar situation)

NCT ID: NCT04263506 Not yet recruiting - Clinical trials for The Study Focus on no Specific Condition

A Vignette-based Randomized Controlled Trial to Evaluate the Impact of Supervisor's Role on Research Practices of Doctoral Students

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

This study aims to evaluate the influence of supervisors on PhD students' research practice (i.e., an environment where there is a lack of opposition to detrimental research practice from the supervisor)